Aehr Test Systems (AEHR) is a Fremont, California-based supplier of burn-in and wafer-level test systems that stress-test AI processors, silicon carbide power devices, silicon photonics and memory chips before shipment. The shares dropped 9.51% to $51.56 in Monday's mid-morning session, versus Friday's close of $56.98, leaving the company's market value near $1.7 billion. The direction was unambiguously lower. No company announcement drove the selling: the stock was already marked down roughly 7% in pre-market trading as the semiconductor complex retreated ahead of a heavy week for AI sentiment.
Monday's pressure was sector-wide. The VanEck Semiconductor ETF fell about 3.4% and the iShares Semiconductor ETF about 3.9% shortly after the open, with memory, logic and equipment names all lower. The proximate causes are macro and event-driven rather than company-specific: the 10-year Treasury yield climbed toward 5.17% after October producer prices rose 6.5% year over year, and markets now fully price a December Fed rate increase. Investors were also squaring positions before NVDA's fiscal third-quarter report on Tuesday and Anthropic's initial public offering later in the week — an offering that may pull capital out of existing AI holdings.
Aehr carries an outsized sensitivity to that narrative. Its five-year beta is roughly 3.3, it remains one of the purest small-cap plays on AI burn-in capacity, and its order book leans on a handful of hyperscale customers. When capital spending expectations wobble, the stock historically moves several times the sector's swing. Monday's 9.5% decline against a peer group down 5%–6% fits that pattern.
No verified news or fundamental catalyst found in company disclosures, filings or analyst actions explains Monday's move. Aehr's most recent results, reported November 2, were strong: fiscal first-quarter revenue of $33.0 million rose about 201% year over year, bookings reached $46.7 million, effective backlog stood near $109.3 million, and management narrowed its fiscal 2027 revenue outlook to $150 million with non-GAAP net income of at least 20% of revenue. Post-earnings target cuts from Jefferies to $140 and Lake Street to $90 reflected broad multiple compression in semicap equipment, not a change in the business.
What remains is a technical assessment: the stock is unwinding an enormous 2026 advance — it is still up more than 160% over 52 weeks even after this drop — and the float is small at roughly 31 million shares, which amplifies moves when sentiment shifts. Trading is consistent with profit-taking and sentiment-driven flows in a high-volatility micro-cap rather than a reassessment of Aehr's order pipeline.
Turnover in Aehr has been heavy all month, with several sessions exceeding 3 million shares against a float near 31 million, and average daily volume around 3 million. The move aligned almost perfectly with semiconductor proxies and with test-equipment peers, while the Dow's futures were only marginally lower — a divergence that places the selling squarely in the AI infrastructure trade rather than the broad market. Technically, the shares are well below their 50-day average near $78 and 200-day average near $76, and Monday's dip puts the November lows back in play, with the $51.47 close from November 2 and the $47.01 intraday low from November 5 as the nearest reference points.
A score of 0 would mean no meaningful news and a move entirely normal for the stock; 100 would mean transformative news and an extreme, rare move. Aehr scores 19 out of 100. The verified news component is weak: there was no company disclosure, and the only driver was a generic sector and macro de-rating of AI-linked semiconductors, material to sentiment but not to Aehr's own fundamentals. The price component is also modest. The 9.51% decline is about 1.6x the stock's average absolute daily move of roughly 6.1% over the past 60 sessions, and moves of this size or larger occurred 16 times in that window. Both components are therefore muted, which produces the low combined score.
The next hard data point is Aehr's fiscal second-quarter report, expected in late December or early January, when investors will focus on bookings and whether Sonoma shipments are scaling at the pace implied by guidance. Two commercial milestones matter more than the quarterly print: a second AI processor from its lead hyperscale customer has completed qualification, with volume expected in calendar 2027, and a major accelerator supplier is installing a wafer-level cell in Taiwan with a high-volume decision to follow. Risks include customer concentration, lumpy order timing, a $150 million target that depends on a ramp not yet realized, and continued multiple compression across semiconductor equipment. Nvidia's guidance and Wednesday's Fed minutes are the near-term swing factors for the whole group.
Tickeron's Trending AI Robots page curates the strongest automated trading strategies operating under current market conditions, drawn from a library of hundreds of AI bots covering thousands of tickers. Bots differ widely by strategy, timeframe, performance metrics and the symbols they trade, so the featured roster rotates as market regimes change. With volatility elevated across AI-linked semiconductor names, reviewing which strategies are actually working right now is a practical first step for systematic traders.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The RSI Indicator for AEHR moved out of oversold territory on November 03, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 31 similar instances when the indicator left oversold territory. In 29 of the 31 cases the stock moved higher. This puts the odds of a move higher at 90%.
The Momentum Indicator moved above the 0 level on November 13, 2026. You may want to consider a long position or call options on AEHR as a result. In 71 of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 84%.
The Moving Average Convergence Divergence (MACD) for AEHR just turned positive on November 03, 2026. Looking at past instances where AEHR's MACD turned positive, the stock continued to rise in 35 of 38 cases over the following month. The odds of a continued upward trend are 90%.
Following a +21.66% 3-day Advance, the price is estimated to grow further. Considering data from situations where AEHR advanced for three days, in 243 of 272 cases, the price rose further within the following month. The odds of a continued upward trend are 89%.
AEHR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 54 of 63 cases where AEHR's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 86%.
The 10-day moving average for AEHR crossed bearishly below the 50-day moving average on October 09, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 88%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AEHR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
The Aroon Indicator for AEHR entered a downward trend on November 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 4 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.970) is normal, around the industry mean (5.670). AEHR has a moderately low P/E Ratio (-232.913) as compared to the industry average of (68.795). Projected Growth (PEG Ratio) (0.927) is also within normal values, averaging (0.801). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (51.813) is also within normal values, averaging (27.897).
The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating steady price growth. AEHR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 74 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AEHR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 77, placing this stock better than average.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of burn-in and test equipment for semiconductor manufacturing
Industry ElectronicProductionEquipment